ZA982254B - Preparation of powder agglomerates - Google Patents

Preparation of powder agglomerates

Info

Publication number
ZA982254B
ZA982254B ZA982254A ZA982254A ZA982254B ZA 982254 B ZA982254 B ZA 982254B ZA 982254 A ZA982254 A ZA 982254A ZA 982254 A ZA982254 A ZA 982254A ZA 982254 B ZA982254 B ZA 982254B
Authority
ZA
South Africa
Prior art keywords
preparation
powder agglomerates
agglomerates
powder
Prior art date
Application number
ZA982254A
Other languages
English (en)
Inventor
Tsong-Toh Yang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25232603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA982254(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA982254B publication Critical patent/ZA982254B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA982254A 1997-03-20 1998-03-17 Preparation of powder agglomerates ZA982254B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82112997A 1997-03-20 1997-03-20

Publications (1)

Publication Number Publication Date
ZA982254B true ZA982254B (en) 1998-09-17

Family

ID=25232603

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982254A ZA982254B (en) 1997-03-20 1998-03-17 Preparation of powder agglomerates

Country Status (26)

Country Link
EP (3) EP2036544B1 (fr)
JP (5) JP3901738B2 (fr)
KR (1) KR100386055B1 (fr)
CN (3) CN100518718C (fr)
AR (1) AR011986A1 (fr)
AT (2) ATE415149T1 (fr)
AU (1) AU741783B2 (fr)
CA (3) CA2706634C (fr)
CL (1) CL2011000050A1 (fr)
CZ (1) CZ295460B6 (fr)
DE (2) DE69828155T2 (fr)
DK (2) DK1393721T3 (fr)
ES (2) ES2316681T3 (fr)
HK (2) HK1021323A1 (fr)
HU (2) HU230274B1 (fr)
ID (1) ID24472A (fr)
IL (1) IL131640A0 (fr)
MY (1) MY120725A (fr)
NO (1) NO328062B1 (fr)
NZ (1) NZ337443A (fr)
PL (3) PL204480B1 (fr)
PT (2) PT1393721E (fr)
SK (1) SK284919B6 (fr)
TW (1) TWI221778B (fr)
WO (1) WO1998041193A1 (fr)
ZA (1) ZA982254B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
AU6852900A (en) * 1999-08-20 2001-03-19 Norton Healthcare Ltd Method to produce powders for pulmonary or nasal administration
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
FI20002177A0 (fi) * 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ITMI20012174A1 (it) * 2001-10-18 2003-04-18 Univ Parma Polvere per somministrazione nasale di farmaci
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
EP1452179A1 (fr) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Nouveau combination d'un puissant agoniste beta 2 de longue duree et un corticosteroid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1654001A2 (fr) * 2003-08-05 2006-05-10 Boehringer Ingelheim International GmbH Medicament pour inhalation comprenant des steroides et un betamimetique
CA2540005A1 (fr) * 2003-09-26 2005-04-07 Schering Corporation Traitement de maladie pulmonaire
WO2005044187A2 (fr) * 2003-10-28 2005-05-19 Glaxo Group Limited Preparations pharmaceutiques inhalables employant de l'anhydrate de lactose, et methodes d'administration desdites preparations
CA2547597A1 (fr) * 2003-12-04 2005-06-16 Pfizer Products Inc. Compositions multiparticulaires a stabilite amelioree
ATE399536T1 (de) * 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
TW201024034A (en) 2008-12-30 2010-07-01 Saint Gobain Abrasives Inc Bonded abrasive tool and method of forming
CA2759041A1 (fr) * 2009-04-24 2010-10-28 Schering Corporation Preparations d'agglomerat utiles dans des inhalateurs a poudre seche
AU2010253776B2 (en) 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
NO2560611T3 (fr) * 2010-04-21 2018-06-02
WO2014144894A1 (fr) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Procedes et systemes de conditionnement de matieres cristallines particulaires
JP6020489B2 (ja) 2014-02-27 2016-11-02 トヨタ自動車株式会社 昇圧コンバータ及びその制御方法
EP3212212B1 (fr) 2014-10-31 2020-09-23 Monash University Formulation de poudre
US10835514B2 (en) * 2016-01-08 2020-11-17 Theron Pharmaceuticals, Inc. Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
DE59100388D1 (de) * 1990-01-29 1993-10-28 Ciba Geigy Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers.
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
WO1993011773A1 (fr) * 1991-12-18 1993-06-24 Aktiebolaget Astra Nouvelle combinaison de formoterol et de budesonide
WO1994014492A2 (fr) 1992-12-18 1994-07-07 Schering Corporation Inhalateur pour medicaments en poudre
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
DK0721331T3 (da) * 1993-10-01 2002-02-11 Astrazeneca Ab Fremgangsmåde
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
ES2197212T3 (es) * 1994-12-22 2004-01-01 Astrazeneca Ab Preparacion terapeutica para inhalacion que contiene la hormona paratiroidea, pth.

Also Published As

Publication number Publication date
JP5523240B2 (ja) 2014-06-18
ID24472A (id) 2000-07-20
PL335742A1 (en) 2000-05-08
CA2706634C (fr) 2012-10-23
NO328062B1 (no) 2009-11-13
HU0600845D0 (en) 2007-01-29
AR011986A1 (es) 2000-09-13
SK284919B6 (sk) 2006-02-02
CN100518718C (zh) 2009-07-29
EP2036544A1 (fr) 2009-03-18
HUP0002029A2 (hu) 2000-11-28
CN1903179A (zh) 2007-01-31
JP3901738B2 (ja) 2007-04-04
EP1393721B1 (fr) 2008-11-26
TWI221778B (en) 2004-10-11
AU741783B2 (en) 2001-12-06
EP2036544B1 (fr) 2016-12-28
DE69828155D1 (de) 2005-01-20
CN1257423A (zh) 2000-06-21
HUP0002029A3 (en) 2001-02-28
DK1393721T3 (da) 2009-03-30
NO994519L (no) 1999-11-19
PL204480B1 (pl) 2010-01-29
ES2316681T3 (es) 2009-04-16
KR20010005520A (ko) 2001-01-15
JP2006152000A (ja) 2006-06-15
MY120725A (en) 2005-11-30
CA2282360A1 (fr) 1998-09-24
DE69840277D1 (de) 2009-01-08
ES2234102T3 (es) 2005-06-16
CN100548277C (zh) 2009-10-14
DK0969816T3 (da) 2005-03-14
NZ337443A (en) 2001-04-27
CN1552310A (zh) 2004-12-08
CA2481868A1 (fr) 1998-09-24
CL2011000050A1 (es) 2011-06-24
DE69828155T2 (de) 2005-12-22
ATE284677T1 (de) 2005-01-15
PL208480B1 (pl) 2011-05-31
PL192441B1 (pl) 2006-10-31
IL131640A0 (en) 2001-01-28
CA2282360C (fr) 2004-11-09
PT969816E (pt) 2005-04-29
HU230274B1 (hu) 2015-11-30
CN1149076C (zh) 2004-05-12
CA2481868C (fr) 2010-06-15
SK128099A3 (en) 2000-06-12
EP0969816B1 (fr) 2004-12-15
EP0969816A1 (fr) 2000-01-12
JP2000510478A (ja) 2000-08-15
HK1061359A1 (en) 2004-09-17
EP1393721A1 (fr) 2004-03-03
CZ323399A3 (cs) 2000-02-16
JP2014037446A (ja) 2014-02-27
JP2010275316A (ja) 2010-12-09
CA2706634A1 (fr) 1998-09-24
PT1393721E (pt) 2009-02-02
NO994519D0 (no) 1999-09-17
AU6537898A (en) 1998-10-12
HU226671B1 (en) 2009-06-29
HK1021323A1 (en) 2000-06-09
WO1998041193A1 (fr) 1998-09-24
JP2010248260A (ja) 2010-11-04
CZ295460B6 (cs) 2005-08-17
ATE415149T1 (de) 2008-12-15
KR100386055B1 (ko) 2003-06-09

Similar Documents

Publication Publication Date Title
HUP0002029A3 (en) Preparation of powder agglomerates
AU5889398A (en) Powder inhaler
HUP0001799A3 (en) Dry powder inhaler
IL116459A0 (en) Powder formulations
GB9626263D0 (en) Powder inhaler
ZA976137B (en) Powder atomizer
SG71877A1 (en) Novel powder compositions
PL341049A1 (en) Agglomerates of particles
PL337723A1 (en) Inhalable tocopherol-stabilised prolyposomic powders
GB2327623B (en) Powder production
MX237827B (en) Clear powder coating
GB9405322D0 (en) Powder cosmetic compositions
GB9405320D0 (en) Powder cosmetic compositions
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB2329582B (en) Powder Puff
GB9609515D0 (en) Powder composition
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
GB2322372B (en) Preparation of 2-Mercaptothiazole
GB2337052B (en) A composition comprising a fine powder
GB9724144D0 (en) Dispersion of powders
GB9421942D0 (en) Preparation of fine powder
EP1044161A4 (fr) Fabrication de particules solides
TW320026U (en) Improved structure of powder spoon
AU1830P (en) Powder Puff Rosa banksiae